NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
This Quarter Return
+20.96%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$976M
AUM Growth
+$976M
(+14%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.05%
Holding
237
New
35
Increased
80
Reduced
33
Closed
30
Top Buys
| 1 |
REV Group
REVG
|
$15.9M |
| 2 |
Shake Shack
SHAK
|
$7.98M |
| 3 |
Skywest
SKYW
|
$7.11M |
| 4 |
Viking Therapeutics
VKTX
|
$6.56M |
| 5 |
OSI Systems
OSIS
|
$6.18M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
$23.1M |
| 2 |
Celsius Holdings
CELH
|
$14.8M |
| 3 |
CBAY
Cymabay Therapeutics
CBAY
|
$10.3M |
| 4 |
Cytokinetics
CYTK
|
$8.56M |
| 5 |
e.l.f. Beauty
ELF
|
$8.14M |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Industrials | 19.31% |
| 3 | Healthcare | 13.08% |
| 4 | Financials | 9.58% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cameco
CCJ
$33.6B
| $6.02M | 0.62% |
138,987
+581
| +0.4% | +$25.2K |
|
52
Day One Biopharmaceuticals
DAWN
$766M
| $5.98M | 0.61% |
361,767
+58,449
| +19% | +$966K |
|
53
Janus International
JBI
$1.41B
| $5.93M | 0.61% |
392,188
+42
| +0% | +$635 |
|
54
Vaxcyte
PCVX
$4.17B
| $5.85M | 0.6% |
85,644
-25,079
| -23% | -$1.71M |
|
55
Freshpet
FRPT
$2.59B
| $5.84M | 0.6% |
50,382
+24,131
| +92% | +$2.8M |
|
56
XPO
XPO
$14.8B
| $5.84M | 0.6% |
47,832
+20,756
| +77% | +$2.53M |
|
57
Elastic
ESTC
$9.17B
| $5.82M | 0.6% |
58,103
+9,349
| +19% | +$937K |
|
58
BellRing Brands
BRBR
$5.27B
| $5.6M | 0.57% |
94,928
+1
| +0% | +$59 |
|
59
Federal Signal
FSS
$7.42B
| $5.6M | 0.57% |
65,976
-169
| -0.3% | -$14.3K |
|
60
Green Brick Partners
GRBK
$3.02B
| $5.51M | 0.56% |
+91,563
| New | +$5.51M |
|
|
EXE
61
Expand Energy Corporation Common Stock
EXE
$23.1B
| $5.46M | 0.56% |
61,500
| – | – |
|
62
Goldman Sachs
GS
$221B
| $5.43M | 0.56% |
13,000
| – | – |
|
63
Cavco Industries
CVCO
$4.22B
| $5.33M | 0.55% |
13,358
+6,638
| +99% | +$2.65M |
|
64
Uber
UBER
$194B
| $5.21M | 0.53% |
67,717
+5,820
| +9% | +$448K |
|
65
ASML
ASML
$290B
| $5.21M | 0.53% |
5,371
+164
| +3% | +$159K |
|
66
Immunocore
IMCR
$1.78B
| $5.03M | 0.52% |
77,455
+25,296
| +48% | +$1.64M |
|
67
Parsons
PSN
$8.4B
| $5M | 0.51% |
60,316
-79,376
| -57% | -$6.58M |
|
|
ITCI
68
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $4.94M | 0.51% |
71,371
+21,127
| +42% | +$1.46M |
|
69
DexCom
DXCM
$30.9B
| $4.91M | 0.5% |
35,427
+27,355
| +339% | +$3.79M |
|
70
Regal Rexnord
RRX
$9.44B
| $4.89M | 0.5% |
27,151
-16,643
| -38% | -$3M |
|
71
GATX Corp
GATX
$5.96B
| $4.83M | 0.49% |
+36,036
| New | +$4.83M |
|
72
Confluent
CFLT
$6.63B
| $4.8M | 0.49% |
157,394
+12,579
| +9% | +$384K |
|
73
Itron
ITRI
$5.53B
| $4.77M | 0.49% |
+51,517
| New | +$4.77M |
|
74
Core & Main
CNM
$12.2B
| $4.74M | 0.49% |
+82,832
| New | +$4.74M |
|
75
On Holding
ONON
$14.6B
| $4.74M | 0.49% |
133,884
+3,652
| +3% | +$129K |
|